Page 353 - ALERGIAS BÁSICAS

● Incremento documentado en el marcador sobre el valor basal durante un periodo
sintomático en al menos dos ocasiones (en caso de niveles persistentes de triptasa
>15 ng, basta con un aumento sobre el valor basal en una ocasión).
● La triptasa sérica total es el marcador de elección, siendo menos específica la
medición en orina de 24 horas de los metabolitos de histamina así como la
prostaglandina D2 o su metabolito 11-β prostaglandina F2 (también procedentes del
basófilo).

BIBLIOGRAFÍA RECOMENDADA

SANCHEZ-BORGES M, ET AL.Diagnosis and Treatment of Urticaria and Angioedema: A
Worldwide Perspective. WAO Journal 2012; 5:125–147.

T. ZUBERBIER, R. ASERO, C. BINDSLEV-JENSEN, ET AL. EAACI/GA2LEN/EDF/WAO guideline:
definition, classification and diagnosis of urticaria. Allergy 2009: 64: 1417–1426

MAGERL, M., ET AL., The definition and diagnostic testing of physical and cholinergic urticarias–
EAACI/GA2LEN/EDF/UNEV consensus panel recommendations. Allergy, 2009. 64(12): p.
1715-21.

KAPLAN AP. EN: ADKINSON, N.F. AND E. Middleton, Middleton’s allergy: principles & practice.
7th ed. 2009, Philadelphia, PA: Mosby/Elsevier.

SOTLAR K, ESCRIBANO L, LANDT O, ET AL. One-Step Detection of c-kit Point Mutations Using
PNA-Mediated PCR-Clamping and Hybridization Probes. Am.J.Pathol 2002;81:677-90.

GONZÁLEZ DE OLANO D, DE LA HOZ CABALLER B, NÚÑEZ LÓPEZ R, ET AL. Prevalence of allergy
and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a
study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy. 2007
Oct;37(10):1547-55.

VALENT P, HORNY H-P, ESCRIBANO L, ET AL.Diagnostic Criteria and Classification of
Mastocytosis: A Consensus Proposal. Leuk.Res. 2001;25:603-25.

DE LA HOZ B, GONZÁLEZ DE OLANO D, ALVAREZ I, ET AL. [Guidelines for the diagnosis, treatment
and management of mastocytosis]. An Sist Sanit Navar. 2008; 31(1):11-32.

VALENT P, HORNY H-P, LI CY, ET AL. Mastocytosis (Mast cell disease). In Jaffe ES, Harris NL,
Stein H, Vardiman JW, eds. World Health Organization (WHO) Classification of Tumours.
Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues., pp 291-302. 2001.

VALENT P, AKIN C, AROCK M, BROCKOW K,ET AL. Definitions, criteria and global classification of
mast cell disorders with special reference to mast cell activation syndromes: a consensus
proposal. Int Arch Allergy Immunol. 2012; 157(3): 215-25.

349